UTEK Pharmalicensing.com Announces New Pricing Model: Pay-per-Click to Expand Listed Opportunities, Extend Reach & Remove Mar...
13 January 2010 - 12:00AM
Business Wire
UTEK Corporation (NYSE Amex:UTK), a leading IP licensing and
innovation services company, is pleased to announce a new pricing
model for its Pharmalicensing online service; the pricing will be
effective starting January 13th.
UTEK’s new Pay-per-Click pricing will create further market
efficiencies for the Company’s leading online licensing and
partnering platform for the pharmaceutical industry. The pricing
will provide additional opportunities for buyers and sellers to
access the platform, and create a larger online IP marketplace.
Pharmalicensing.com currently directs more than 190,000 visitors
each month to emerging partnering opportunities posted by companies
worldwide.
“In 2009, we spent considerable effort listening to our clients
on how we might serve the marketplace better. I believe this
pricing change will further extend our lead and continue to make
our marketplace the most efficient and highly trafficked online
licensing platform in the pharmaceutical sector.” Mark McBride,
Managing Director of UTEK Pharmalicensing continues, “Our
Pay-per-Click option is intended to remove pricing barriers for
users of our service, increasing our base of potential clients. We
continue to take as much risk as possible out of our clients’
partner search process, and offer our visitors more opportunities
to fill their drug pipelines.”
All new clients will be eligible for the pricing structure,
which will enable companies to post their profile and only pay for
qualified traffic. Pay-per-Click clients will pay only for the
partnering opportunities or potential partner click-throughs they
receive. The Company plans to expand the new pricing model to its
Medical Device Licensing platform as well as additional licensing
platforms to be launched in 2010.
For more information please visit: www.pharmalicensing.com or
www.utekcorp.com
About UTEK Corporation
UTEK® is a leading global IP licensing and innovation services
company. UTEK’s services enable its clients to enhance their
innovation capabilities, rapidly source externally developed
technologies, create value from their intellectual property and
gain foresight into marketplace and technology developments that
could affect their business. For more information about UTEK,
please visit its website at www.utekcorp.com.
Forward-Looking Statements
Certain matters discussed in this press release are
“forward-looking statements.” These forward looking statements can
generally be identified as such because the context of the
statement will include words such as UTEK “expects,” “should,”
“believes,” “anticipates” or words of similar import. Certain
factors could cause actual results to differ materially from those
projected in these forward looking statements and these factors are
identified from time to time in our filings with the Securities and
Exchange Commission. We undertake no obligation to publicly update
or revise any forward-looking statements, whether as a result of
new information, future events or otherwise. This press release is
available on UTEK’s website www.utekcorp.com
Utek (AMEX:UTK)
Historical Stock Chart
From Jun 2024 to Jul 2024
Utek (AMEX:UTK)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Utek Corp. (American Stock Exchange): 0 recent articles
More UTEK Corporation News Articles